Evogene Ltd. (EVGN) vs WORK Medical Technology Group Ltd. Class A (WOK)
A side-by-side comparison of Evogene Ltd. and WORK Medical Technology Group Ltd. Class A across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EVGN
Evogene Ltd.
$0.42HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WOK
WORK Medical Technology Group Ltd. Class A
$1.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — EVGN vs WOK
growth of $100 · dividends reinvested · last 2yEVGN -90.0% (-68.4%/yr)WOK -100.0% (-99.9%/yr)EVGN compounded faster over this window
Log scale — wide-divergence pair
EVGN WOK
EVGN vs WOK: by the numbers
- •EVGN is the larger company ($4M vs $4M market cap).
- •Both run net losses; WOK's is the smaller (-10.89% vs -694.19% net margin).
- •EVGN grew revenue faster over the past five years (2.86% vs -28.44% CAGR).
Metrics side by side
Valuation
| Metric | EVGN | WOK |
|---|---|---|
| P/S ratio | 2.79 | N/A |
| P/B ratio | N/A | 0.12 |
Profitability
| Metric | EVGN | WOK |
|---|---|---|
| Gross margin | -6.25% | 23.81% |
| Operating margin | -364.24% | -25.34% |
| Net margin | -694.19% | -10.89% |
| ROE | N/A | -5.85% |
| ROIC | -130.12% | -9.04% |
Growth (annualized)
| Metric | EVGN | WOK |
|---|---|---|
| Revenue CAGR (5Y) | 2.86% | -28.44% |
| Total return CAGR (5Y) | -56.46% | N/A |
Frequently asked
- Which has grown faster, EVGN or WOK?
- Over the past five years, EVGN grew revenue faster — EVGN at a 2.86% CAGR versus WOK at -28.44%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.